YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases-Reference-Cited by-同舟云学术

YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases

Published:2021-08-11 Issue:12 Volume:34 Page:2211-2221
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Dermawan Josephine K.^ORCID,Azzato Elizabeth M.,Billings Steven D.^ORCID,Fritchie Karen J.^ORCID,Aubert Sebastien,Bahrami Armita,Barisella Marta,Baumhoer Daniel^ORCID,Blum Veronika,Bode Beata^ORCID,Aesif Scott W.,Bovée Judith V. M. G.^ORCID,Dickson Brendan C.^ORCID,van den Hout Mari,Lucas David R.,Moch Holger^ORCID,Oaxaca Gabriel,Righi Alberto^ORCID,Sciot Raf^ORCID,Sumathi Vaiyapuri,Yoshida Akihiko^ORCID,Rubin Brian P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00879-7.pdf

Reference34 articles.

1. Antonescu, C. R. et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer 52, 775–784 (2013).

2. Flucke, U. et al. Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn. Pathol. 9, 131 (2014).

3. Patel, N. R. et al. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants. Histopathology 67, 699–708 (2015).

4. Puls, F., Niblett, A., Clarke, J., Kindblom, L. G. & McCulloch, T. YAP1-TFE3 epithelioid hemangioendothelioma: a case without vasoformation and a new transcript variant. Virchows Arch. 466, 473–438 (2015).

5. Lee, S. J., Yang, W. I., Chung, W. S. & Kim, S. K. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements. Oncotarget 7, 7480–7408 (2016).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A genetic basis for sex differences in Xp11 translocation renal cell carcinoma;Cell;2024-08

2. CDK9 Inhibition by Dinaciclib Is a Therapeutic Vulnerability in Epithelioid Hemangioendothelioma;Clinical Cancer Research;2024-07-25

3. YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer;Annual Review of Cancer Biology;2024-06-12

4. Proposed diagnostic and prognostic markers of primary malignant hepatic vascular neoplasms;Diagnostic Pathology;2024-05-13

5. Vascular tumors of intermediate malignancy: An update;Human Pathology;2024-05